What tasks are humanoids uniquely good at and what does that mean for the future of work?

In Episode 2 of Cell Mates, we invite Tony Yang, Director of North American Markets from Unitree Robotics to discuss the future of humanoid robots and how robots can fundamentally change the future. We explore in particular what this means for the biomanufacturing industry.

Highlights include:

• Where do humanoids fit in pharma?
• What makes robotic adoption difficult (yet inevitable)?
• What could a future filled with humanoids could look like?

This episode breaks down what the robotic future might actually look like, and how close we are to building it!

New to Cell Mates? We're the podcast where pharma, robotics, and automation collide to reimagine the future of medicine—one operation at a time.

What happens when scientists and engineers collaborate to tackle the biggest challenges in pharma manufacturing? In this debut episode, Multiply Labs CEO Frederico Parietti, Ph.D., sits down with Sanket Acharya, Ph.D., Senior Director of Corporate Development at GenScript, to explore the critical intersection of science and automation.

Key topics we cover:
⚙️ What engineers often misunderstand about science
🔬 What scientists often get wrong about engineering
🤝 How cross-disciplinary collaboration drives innovation in pharma manufacturing
🤖 The role of automation and robotics in scaling personalized therapies

At Multiply Labs, we believe that automation is the future of pharma manufacturing—and that bridging the gap between disciplines is key to unlocking new breakthroughs. Cell Mates brings you candid conversations with industry leaders who are shaping the future of cell and gene therapy manufacturing.

🎧 Listen to the full episode now and join the conversation! Don’t forget to like, comment, and subscribe to stay updated on future episodes.